Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease

DOI: 10.1001/jamacardio.2023.2222Author: Seung-Jun Lee et al.Published: 2023-9-1

Title: Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease
Journal: JAMA Cardiology
Authors: Seung-Jun Lee, Jung-Joon Cha, Woong Gil Choi, Wang-Soo Lee, Jin-Ok Jeong, Seonghoon Choi, Yoon-Haeng Cho, Woojung Park, Chang-Hwan Yoon, Yong-Joon Lee, Sung-Jin Hong, Chul-Min Ahn, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Soon Jun Hong, Jung-Sun Kim, RACING Investigators, Kyeong Ho Yun, Bum-Kee Hong, Jung Ho Heo, Won Young Jang, Won-Yong Shin, Sang Wook Im, Woong Chol Kang, Young Hoon Jung, Yongwhi Park, Sung Yoon Lee, Seung Ho Hur, Hyun Hee Choi, Kyoung Jin Kim, Ju Han Kim, Hyun Kuk Kim, Jung Hee Lee, Ung Kim, Yu-Jung Choi, Seung-Woon Rha, Yun-Hyeong Cho
Date: 2023-9-1
DOI: 10.1001/jamacardio.2023.2222
Source: American Medical Association (AMA)
Source URL: https://doi.org/10.1001/jamacardio.2023.2222